ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

MIST Milestone Pharmaceuticals Inc

1.64
0.04 (2.50%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Milestone Pharmaceuticals Inc MIST NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.04 2.50% 1.64 15:04:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.58 1.58 1.71 1.64 1.60
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/3/202408:00EDGAR2Form 8-K - Current report
01/3/202415:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202406:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
28/2/202415:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
26/2/202406:06EDGAR2Form 8-K - Current report
14/2/202419:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202406:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/12/202307:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
26/12/202306:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
26/12/202306:15EDGAR2Form 8-K - Current report
21/11/202306:00PRNUSMilestone Pharmaceuticals to Present at the Piper Sandler..
13/11/202306:05EDGAR2Form 8-K - Current report
13/11/202305:57PRNUSMilestone Pharmaceuticals Reports Third Quarter 2023..
13/11/202305:37EDGAR2Form 8-K - Current report
13/11/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202309:00PRNUSMilestone Pharmaceuticals Presents Positive Results from..
09/11/202315:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/11/202308:07EDGAR2Form 8-K - Current report
07/11/202306:00PRNCAMilestone Pharmaceuticals to Host Investor and Analyst..
24/10/202315:05EDGAR2Form 8-K - Current report
24/10/202306:00PRNCAMilestone Pharmaceuticals Announces Submission of New Drug..
06/10/202306:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
27/9/202306:00PRNCAMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
05/9/202306:00PRNCAMilestone Pharmaceuticals to Present at the H.C. Wainwright..
10/8/202306:40EDGAR2Form 8-K - Current report
10/8/202306:35PRNUSMilestone Pharmaceuticals Reports Second Quarter 2023..
10/8/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/6/202306:00PRNCAMilestone Pharmaceuticals Announces Publication of Results..
01/6/202306:00PRNCAMilestone Pharmaceuticals to Present at the Jefferies..
22/5/202306:00PRNUSMilestone Pharmaceuticals Announces Presentation of Data..
11/5/202306:16PRNCAMilestone Pharmaceuticals Reports First Quarter 2023..
08/5/202306:00PRNUSMilestone Pharmaceuticals to Host Virtual Key Opinion Leader..

Su Consulta Reciente

Delayed Upgrade Clock